DEC 23, 2019 9:49 AM PST

Long awaited at-home test gives hemophiliacs peace of mind

WRITTEN BY: Tara Fernandez

Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. Blood clotting is a natural protective response, orchestrated by circulating proteins known as clotting factors.

In the event of an internal or external bleed, a cascade of hematological events is quickly triggered to minimize damage. Firstly, blood vessels shrink to constrict blood flow. Next, blood cells called platelets are activated and interact with other blood proteins, such as fibrin, to create a mesh dam-like structure. The video below highlights the complex biology of the clotting process.

 

Managing hemophilia involves a delicate balance of measuring a patient’s coagulation status, or the ability of their blood to form a clot, and then administering an appropriate therapeutic dose of a clotting factor. If the coagulation status is too low, the patient risks massive internal bleeding. Too high, and blood clots can spontaneously form in veins and arteries, spiking the risk of a heart attack or stroke.

Japanese pharmaceutical giant, Takeda, in partnership with technology developed by Dutch biotech, Enzyre, is creating the first diagnostic test for hemophilia patients -- allowing them to measure their coagulation status accurately from the comfort of their own homes.

This development is a long time coming for the 400,000 people living with hemophilia around the world, who mostly manage their condition on their own, only seeking medical care when urgently required. An at-home diagnostic tool can provide much greater control over managing their health effectively.

The device, known as the ENZYPAD (pictured below), painlessly takes a sample of blood from the patient and runs the test on a microfluidic cartridge. The test results are instantly available to patients, caregivers and their physicians via a mobile app. With this life-changing technology, patients can confidently lead active lifestyles without worrying about their risk of bleeding or having to perform traditional blood tests at a hospital.

Inspired by creating solutions to improve hemophiliacs’ quality of life, Dirk Pollet, CEO of Enzyre said, “With our proprietary technology, we aim to provide hemophilia patients and their caregivers with peace of mind by allowing them to monitor coagulation status at home. Ultimately we'd like to empower these patients to live a normal life.”

Other pharmaceutical companies, such as Pfizer and Sangamo Therapeutics are also developing clinical strategies to support hemophiliacs, by taking a gene therapy approach. They recently disclosed some promising results from a gene therapy clinical trial, in which the gene for Factor VIII (the missing link for patients with Hemophilia A) was delivered to the liver of patients. This stimulates the liver to act as a factory for Factor VIII, bringing circulating levels of the clotting factor up towards the normal range and protecting against bleeding.

With improved point-of-care diagnostics and next-generation therapies for hemophilia just around the corner, families living with hemophilia can expect much more peace of mind.



Sources: Fierce Biotech, NHS, Hemophilia News Today.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially ...
JAN 06, 2020
Genetics & Genomics
JAN 06, 2020
Some Genetic Sequencing Tests Are Coming Up Short
If it's suspected that a person has a genetic disease, doctors might send the patient's DNA for sequencing. But some seq ...
JAN 11, 2020
Neuroscience
JAN 11, 2020
Molecular Therapy to Self-Repair Nerve Cells
Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated ...
APR 02, 2020
Clinical & Molecular DX
APR 02, 2020
Diagnosing Antisocial Personality Disorder
Antisocial personality disorder (APD), a mental disorder, is sometimes referred to as sociopathy. Persons with the disor ...
APR 23, 2020
Immunology
APR 23, 2020
COVID "Immunity Passports" Are a No-Go
  Authorities are caught between dealing with the competing urgencies of abating the COVID-19 health crisis and the ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
Loading Comments...